Atomistry » Chlorine » PDB 6zpd-6zyu » 6zug
Atomistry »
  Chlorine »
    PDB 6zpd-6zyu »
      6zug »

Chlorine in PDB 6zug: Crystal Structure of Thrombin in Complex with COMPOUND10

Enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND10

All present enzymatic activity of Crystal Structure of Thrombin in Complex with COMPOUND10:
3.4.21.5;

Protein crystallography data

The structure of Crystal Structure of Thrombin in Complex with COMPOUND10, PDB code: 6zug was solved by M.Schafer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 31.78 / 1.80
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 70.151, 71.058, 72.316, 90.00, 100.27, 90.00
R / Rfree (%) 16.9 / 21.2

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Thrombin in Complex with COMPOUND10 (pdb code 6zug). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Thrombin in Complex with COMPOUND10, PDB code: 6zug:

Chlorine binding site 1 out of 1 in 6zug

Go back to Chlorine Binding Sites List in 6zug
Chlorine binding site 1 out of 1 in the Crystal Structure of Thrombin in Complex with COMPOUND10


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Thrombin in Complex with COMPOUND10 within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Cl1001

b:33.2
occ:1.00
CL1 H:QPW1001 0.0 33.2 1.0
C22 H:QPW1001 1.7 32.2 1.0
C24 H:QPW1001 2.7 31.4 1.0
C20 H:QPW1001 2.8 31.4 1.0
O H:PHE227 3.3 32.1 1.0
O H:TRP215 3.4 33.1 1.0
N H:PHE227 3.6 30.4 1.0
CG1 H:VAL213 3.6 30.6 1.0
N H:TRP215 3.6 32.1 1.0
CA H:GLY226 3.7 31.7 1.0
C H:TRP215 3.7 32.2 1.0
N H:SER214 3.8 30.2 1.0
C H:GLY226 3.9 30.8 1.0
C23 H:QPW1001 4.0 32.2 1.0
CZ H:TYR228 4.0 29.8 1.0
C19 H:QPW1001 4.1 32.0 1.0
CA H:TRP215 4.1 33.6 1.0
C H:SER214 4.1 31.1 1.0
C H:PHE227 4.1 30.9 1.0
OH H:TYR228 4.2 31.2 1.0
CE2 H:TYR228 4.2 28.9 1.0
CE1 H:TYR228 4.3 31.2 1.0
CB H:ALA190 4.3 33.1 1.0
N H:GLY216 4.4 33.3 1.0
CA H:PHE227 4.5 30.8 1.0
CA H:VAL213 4.5 29.7 1.0
C H:VAL213 4.5 30.2 1.0
C21 H:QPW1001 4.5 32.1 1.0
CA H:SER214 4.5 31.6 1.0
CB H:VAL213 4.6 31.0 1.0
O H:SER214 4.7 33.8 1.0
CD1 H:TYR228 4.7 30.3 1.0
CD2 H:TYR228 4.7 29.1 1.0
OD1 H:ASP189 4.8 34.7 1.0
O H:HOH1166 4.9 33.5 1.0
O H:GLY226 4.9 30.4 1.0
CG H:TYR228 4.9 29.3 1.0

Reference:

A.Hillisch, K.M.Gericke, S.Allerheiligen, S.Roehrig, M.Schaefer, A.Tersteegen, S.Schulz, P.Lienau, M.Gnoth, V.Puetter, R.C.Hillig, S.Heitmeier. Design, Synthesis, and Pharmacological Characterization of A Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. J.Med.Chem. V. 63 12574 2020.
ISSN: ISSN 0022-2623
PubMed: 33108181
DOI: 10.1021/ACS.JMEDCHEM.0C01035
Page generated: Mon Jul 29 18:11:46 2024

Last articles

Cl in 3N5W
Cl in 3N5U
Cl in 3N54
Cl in 3N5J
Cl in 3N5L
Cl in 3N5H
Cl in 3N5C
Cl in 3N4E
Cl in 3N4A
Cl in 3N2L
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy